Higher ADK levels track stronger triciribine effects in leukemia cells, pointing to a potential biomarker

Дата публикации: 19-10-2026 23:20:07

In a comprehensive study of acute lymphoblastic leukemia, researchers at Karolinska Institutet have shown that the enzyme ADK plays an important role in determining how leukemia cells respond to triciribine. Published in npj Precision Oncology, the study also provides new insights into how the compound works and identifies ADK as a potential biomarker for predicting its effects on leukemia cells.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Epigenetic mapping provides deeper insight into leukemia	5	8	09-07-2026
2	Baseline Extracellular HMGB-1 Levels Associated with Induction Chemotherapy Response in Adult Acute Myeloid Leukemia [version 1; peer review: 2 approved with reservations]	0	7.88	11-07-2026
3	New study reveals how blood cancers outsmart BTK-targeted therapies	0	8.1	28-07-2026
4	Cardioprotection limited in adult hematologic malignancies	0	12.26	13-10-2026
5	Common leukemia mutation derails protein positioning during cell division, study reveals	0	5.4	14-10-2026
6	Современные подходы и возможности в выборе терапии ALK+ НМРЛ	0	10.06	21-01-2026
7	How RNA molecules influence the development of aggressive leukemia	0	8.25	14-10-2026
8	Malaga searches for 'switch' that halts most aggressive phase of blood cancer	0	10	13-05-2026
9	Chemotherapy leaves detectable DNA fingerprints in childhood tumors within 18 months	0	8.21	23-07-2026
10	Long and interstate travel may be a barrier to care for certain pediatric cancer patients	0	11.28	19-10-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5.18. Источник: medicalxpress.com.